Aytu Biopharma (AYTU) Shareholder's Equity (2011 - 2026)

Aytu Biopharma (AYTU) Shareholder's Equity (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.23 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.75 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 446.17 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.21 Bn
10 Aytu Biopharma 24.60 Mn -2.12 Mn 7.60 Mn 35.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.14 Mn
Dec 31, 2025 14.20 Mn
Sep 30, 2025 23.17 Mn
Jun 30, 2025 18.97 Mn
Mar 31, 2025 34.90 Mn
Dec 31, 2024 30.77 Mn
Sep 30, 2024 29.83 Mn
Jun 30, 2024 27.72 Mn
Mar 31, 2024 30.78 Mn
Dec 31, 2023 32.85 Mn
Sep 30, 2023 32.17 Mn
Jun 30, 2023 39.36 Mn
Mar 31, 2023 40.91 Mn
Dec 31, 2022 45.82 Mn
Sep 30, 2022 48.35 Mn
Jun 30, 2022 44.31 Mn
Mar 31, 2022 61.14 Mn
Dec 31, 2021 105.54 Mn
Sep 30, 2021 111.50 Mn
Jun 30, 2021 137.57 Mn